Excerpt Study on IMUREGEN Final Report
Three months of study were conducted on 30 seniors. Fifteen individuals were given a placebo, and the other half with IMUREGEN.
SOURCE: Book of Clinical Studies.
Graph 1.: Rheumatic factor before and after supplementing of seniors
Summary Results
The evaluation of the results is that individuals with and without supplements were burdensome, mainly because of the age heterogenesis of the group. Often, there were pronounced changes at entry check-ups, which often signal serious illness.
Despite this, we have noticed a significant influence in the inflammation markers, where we have proved a decrease in values of C-reactive protein from 75 to 43 mg/l (P=0,01).
In connection with this, we have found improvement in values of complement’s components – mainly C3; there was an increase from 96 to 123 mg (p=0,001).
It is also important to increase the value of pre-albumin from 0,221 mg/l to 233 mg/l, primarily because of its decrease in the control from 0,219 to 0,174 mg/l (p=0,047).
It shows significant improvement in nutritional state. After three months of supplementation, a significant decrease (p=0,0039) compared to the control group (graph 1.).
It corresponds with a significant decrease in circulating immune complexes’ values, while in the control group, an increase in values occurred.
Improvement in the quality of immune response even after short-term supplementation is documented by an increase in mean values of natural antibodies (“xenoaglutinin”), which didn’t show any change in the control group. [SOURCE: Book of Clinical Studies]
FURTHER READING:
Imuregen Independent Review.
Frequently Asked Questions on Imuregen.
Time-release IMMUNE +++ Supplement.
